CORRECTION article

Front. Oncol., 15 December 2022

Sec. Thoracic Oncology

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1118042

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

  • WZ

    Wei Zhang 1

  • WW

    Weiwei Wang 1,2

  • JW

    Junlu Wu 1

  • JT

    Jiale Tian 1

  • WY

    Wenhui Yan 3

  • YY

    Yi Yuan 1

  • YY

    Yiwen Yao 4

  • AS

    Anquan Shang 1*

  • WQ

    Wenqiang Quan 1*

  • 1. Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China

  • 2. Department of Pathology, Tinghu People’s Hospital, Yancheng, China

  • 3. Department of Laboratory Medicine, Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji Univeirsity School of Medicine, Shanghai, China

  • 4. Department of Internal Medicine V-Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg, Germany

Article metrics

View details

964

Views

743

Downloads

In the published article, an author name was incorrectly written as Wenqian Quan. The correct spelling is Wenqiang Quan.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

NLR, LMR, HNR, NSCLC, risk assessment, diagnostic markers

Citation

Zhang W, Wang W, Wu J, Tian J, Yan W, Yuan Y, Yao Y, Shang A and Quan W (2022) Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis. Front. Oncol. 12:1118042. doi: 10.3389/fonc.2022.1118042

Received

07 December 2022

Accepted

08 December 2022

Published

15 December 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2022

Updates

Copyright

*Correspondence: Anquan Shang, ; Wenqiang Quan,

†The authors have contributed equally to this work

This article was submitted to Thoracic Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics